Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pretax income is the income that a company earns before paying income taxes. 2seventy bio's pretax income for the
three
months ended in Mar. 2025 was MXN9.9 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Mar. 2025 was MXN-137.0 Mil.
2seventy bio's pretax margin was 2.10%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
2seventy bio Pre-Tax Income Related Terms
2seventy bio Pre-Tax Income Historical Data
* Premium members only.
The historical data trend for 2seventy bio's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:TSVT vs ALMS, TERN, CRVS: Pre-Tax Income Comparison
For the Biotechnology subindustry, 2seventy bio's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
2seventy bio Pre-Tax Income vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, 2seventy bio's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where 2seventy bio's Pre-Tax Income falls into.
Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-137.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
2seventy bio (MEX:TSVT) has a Pre-Tax Income of MXN-137.0 Mil as of Mar. 2025. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on 2seventy bio and its competitors.
Is 2seventy bio's Pre-Tax Income too high?
2seventy bio's current Pre-Tax Income is MXN-137.0 Mil. Overall, 2seventy bio has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does 2seventy bio's Pre-Tax Income compare to ALMS and TERN?
2seventy bio's Pre-Tax Income of MXN-137.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pre-Tax Income for a Biotechnology company?
A good Pre-Tax Income depends on the Biotechnology industry context. However, Pre-Tax Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pre-Tax Income mean?
A high Pre-Tax Income can signal that a stock is expensive relative to its fundamentals. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on 2seventy bio and its competitors. 2seventy bio's current Pre-Tax Income is MXN-137.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 2seventy bio stock overvalued right now?
2seventy bio (MEX:TSVT) has a current Pre-Tax Income of MXN-137.0 Mil. The current Pre-Tax Income is MXN-137.0 Mil. 2seventy bio's overall GF Score™ is 9/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pre-Tax Income calculated?
Pre-Tax Income is calculated from a company's financial statements. For 2seventy bio (MEX:TSVT), the current Pre-Tax Income is MXN-137.0 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment focusing on researching, developing and commercializing potentially transformative treatments for cancer.
9GF Score
Get the complete analysis for MEX:TSVT
Pre-Tax Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:TSVT has been successfully added to your 
